In the original publication [1], there was a mistake in Figure 6E as published. The corrected Figure 6 appears below.
Figure 6.
Magnolol (MG) inhibited the activation of NLRP3 inflammasome in PA-induced steatosis and lipopolysaccharide (LPS)-challenged HepG2 cells. (A) IL-1β protein levels in the supernatant fraction of steatotic cells; (B) representative Western blot and densitometry analysis of NLRP3, ASC, caspase1 p20, and procaspase1 p50 in steatotic cells; (C) IL-1β protein levels in the supernatant fraction of LPS-challenged cells; (D) representative Western blot and densitometry analysis of caspase1 p20, procaspase1 p50, IL-6, and TNF-α in LPS-challenged cells; (E) representative Western blot and densitometry analysis of autophagy-related markers LC3B, ATG7, p62/SQSTM1, and mTOR in steatotic cells. Data are expressed as mean ± SEM, n = 4. * p < 0.05 vs. Ctrl; + p < 0.05 vs. MG; # p < 0.05 vs. PA; & p < 0.05 vs. LPS.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Kuo, N.-C.; Huang, S.-Y.; Yang, C.-Y.; Shen, H.-H.; Lee, Y.-M. Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro. Antioxidants 2020, 9, 924. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).